Drug ID: | NPD4379 |
Drug Name: | |
Molecular Formula: | C21H20O6 |
Canonical SMILES: | COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(c(c2)OC)O)ccc1O |
Standard InCHI: | InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+ |
Standard InCHIKey: | VFLDPWHFBUODDF-FCXRPNKRSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DCL001107; DNC006900 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 969516 |
ChEBI | |
CAS Number |
Molecular Weight | 368.13 |
ALogP | -0.7948 |
MLogP | 3.11 |
XLogP | 2.847 |
HDA | 2 |
HBD | 2 |
Rotatable Bonds | 12 |
TPSA | 93.06 |
RO5 Violation | 0 |